HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Zoledronic acid is effective in preventing and delaying skeletal events in patients with bone metastases secondary to genitourinary cancers.

AuthorsFred Saad, Allan Lipton
JournalBJU international (BJU Int) Vol. 97 Issue 6 Pg. 1351-2 (Jun 2006) ISSN: 1464-4096 [Print] England
PMID16686742 (Publication Type: Letter, Comment)
Chemical References
  • Bone Density Conservation Agents
  • Diphosphonates
  • Imidazoles
  • Zoledronic Acid
Topics
  • Bone Density Conservation Agents (therapeutic use)
  • Bone Neoplasms (drug therapy)
  • Bone Resorption (prevention & control)
  • Diphosphonates (therapeutic use)
  • Humans
  • Imidazoles (therapeutic use)
  • Magnesium Deficiency (chemically induced)
  • Male
  • Prostatic Neoplasms (drug therapy)
  • Urogenital Neoplasms
  • Zoledronic Acid

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: